RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 34-44
  • An O.C. couple do the math: Same drug is far cheaper in Canada

    An O.C. couple do the math: Same drug is far cheaper in Canada
    Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare. Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
  • Janus' Kozlowski seeks stocks immune to market malaise

    BOSTON (Reuters) - Concerned that trends in the economy may not help stock prices much, Janus Capital Group's Dan Kozlowski is looking for companies that can help themselves. As manager of the $4.2 billion Janus Contrarian Fund, Kozlowski has posted...
  • Use of experimental Ebola drug raises red flags among medical experts

    Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
  • American Ebola patients become serum test subjects

    American Ebola patients become serum test subjects
    There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
  • Who gains from those drug discount deals? (Spoiler: Drug companies)

    The pharmaceutical industry has been bragging for nearly a decade now about its efforts to help cash-strapped patients pay for expensive prescription drugs.  "An important safety net," the industry says, that has "already helped millions of Americans...
  • New Haven's Marinus Pharmaceuticals Goes Public

    Marinus Pharmaceuticals, an eight-person company working on a drug that may be effective against epileptic seizures, went public Thursday with a stock price of $8 a share. The shares traded as high as $8.16 on Thursday on the NASDAQ exchange, and...
  • Pfizer Slightly Beats Expectations, Leaves Investors Guessing About AstraZeneca

    Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals. The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
  • Allergan to slash workforce by 1,500

    Allergan to slash workforce by 1,500
    Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival. Stung by criticism that it'...
  • Pill look different? Shape and color changes may prompt lapses

    Pill look different? Shape and color changes may prompt lapses
    In a decade, Americans have saved an estimated $1.2 trillion by taking generic drugs instead of the high-priced originals. But the booming market in copycat prescription pharmaceuticals - coupled with insurance companies' efforts to keep healthcare...
  • Abbott to sell generics in major markets to Mylan for $5.3 billion

    Abbott to sell generics in major markets to Mylan for $5.3 billion
    Abbott Laboratories has agreed to sell its specialty and branded generic pharmaceutical business in developed markets to Pennsylvania-based Mylan Inc. in an all-stock transaction valued at about $5.3 billion. The deal, which will give Abbott a roughly...